ѻý

Galantamine and Alzheimer's; Fork Sign Landmark; Instagram in Neurology Education

<ѻý class="mpt-content-deck">— News and commentary from the world of neurology and neuroscience
MedpageToday
Neuro Break over a computer rendering of neurons.

Galantamine , functional ability, and behavior at 6 months in people with Alzheimer's dementia, but no evidence supported its use in people with mild cognitive impairment. (Cochrane Database of Systematic Reviews)

Researchers point to the as a landmark for identifying central sulcus region structures on sagittal MRI images, including the motor hand area. (Brain Communications)

A small study suggested transcranial direct current stimulation may but could be harmful to others. (npj Parkinson's Disease)

Researchers identified eight alternative and off-label treatments that target at least one of the underlying mechanisms in (ALS). (Annals of Neurology)

Dementia-related , Lancet Neurology editors maintained.

Accelerated was linked with progression to mild cognitive impairment. (JAMA Network Open)

How should clinicians manage comatose patients with after cardiac arrest? (JAMA Neurology)

Instagram could help further and neuroscience, a researcher argued. (Neurology: Education)

Berislav Zlokovic, MD, PhD, a prominent at the University of Southern California who faced scrutiny for possible misconduct, is on an indefinite leave of absence. (Science)

A case report assessed the effect of continuous (Kesimpta) during pregnancy in a patient with multiple sclerosis. (Neurology Clinical Practice)

  • Judy George covers neurology and neuroscience news for ѻý, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.